Bay State Biotech Report: Advaxis and Cervical Cancer

Bloomberg biotech reporter Doni Bloomfield spoke with Advaxis CEO Daniel O’Connor about the company’s drug to treat recurrent carcinoma of the cervix by using a tweaked bacteria to awaken the immune system. That’s all on the Bay State Biotech Report, where Bloomberg biotechnology reporter Doni Bloomfield and Boston radio host Anne Mostue discuss the latest in biotech news from the Boston area and across the nation.

producer: Anne Mostue +1-617-210-4662 or amostue@bloomberg.net.

Running time 05:29

Before it's here, it's on the Bloomberg Terminal. LEARN MORE